by Ryan Jaslow, Harvard Medical School Preliminary findings from Harvard Medical School researchers at Massachusetts Eye and Ear may pave the way for trials to test bone density medications for hearing loss. Hearing loss caused by damaged nerves, whether from sound exposure or aging, is irreversible. There are currently no medications approved by the Food...
by University of Granada Scientists from the research group CIBERFES and the University of Granada (UGR) have implemented a protocol for effectively detecting hypophosphatasia and have discovered two new genetic mutations associated with this disease, which is often confused with other bone ailments. Extrapolating the data from their study, published in Scientific Reports, they estimate that between...
Providing expert insights on the pathogenesis and management of rare skeletal diseases such as fibrous dysplasia, Fibrogenesis Imperfecta Ossium, Melorheostosis, Osteopoikilosis, Camurati-Engelmann disease, osteomyelitis and Paget’s disease. INTERNATIONAL OSTEOPOROSIS FOUNDATION Recently, extraordinary progress has been made in our understanding of the mechanisms and molecular pathways underlying focal and sclerotic bone diseases, rare disorders which have a strong...
